Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KARPATI, G.
Right arrow Articles by MAMER, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KARPATI, G.
Right arrow Articles by MAMER, O. A.
NEUROLOGY 1975;25:16
© 1975 American Academy of Neurology

The syndrome of systemic carnitine deficiency

Clinical, morphologic, biochemical, and pathophysiologic features

GEORGE KARPATI, M.D., STIRLING CARPENTER, M.D., ANDREW G. ENGEL, M.D., GORDON WATTERS, M.D., JEFFREY ALLEN, M.D., STANLEY ROTHMAN, M.D., GERALD KLASSEN, M.D. and ORVAL A. MAMER, Ph.D.

Departments of Neurology and Neurosurgery, Pediatrics, and Medicine, McGill University, Montreal, Canada, and the Mayo Clinic and Mayo Foundation, Rochester, Minnesota (Dr. Engel).

An 11 -year-old boy had had recurrent episodes of hepatic and cerebral dysfunction and underdeveloped musculature. Overt weakness developed at age 10. Lipid excess, especially in type I fibers, was found in muscle. Hypertrophied smooth endoplasmic reticulum and excessive microbodies were present in liver. Marked carnitine deficiency was shown in skeletal muscle, plasma, and liver. Ketogenesis was impaired on a high fat diet, but omega oxidation of fatty acids was enhanced. There was excessive glucose uptake and essentially no oxidation of labeled long-chain fatty acids by perfused forearm muscles in vivo. Oral replacement therapy restored plasma carnitine levels to normal, but not liver or muscle carnitine levels, and was accompanied by clinical improvement.

This study was supported in part by the Muscular Dystrophy Association of Canada, the Medical Research Council of Canada, The Isaac Walton Killam Memorial Fund of the Montreal Neurological Institute, and by USPHS grant NS6277 (Dr. Engel).

Received for publication August 5, 1974.

Dr. Karpati's address is Montreal Neurological Institute, 3801 University St., Montreal, Que., Canada H3A 2B4.




This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
E. Gilbert-Barness
Metabolic Cardiomyopathy and Conduction System Defects in Children
Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 15 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Gourie-Devi, A Nalini, and S Sandhya
Early or late appearance of "dropped head syndrome" in amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry, May 1, 2003; 74(5): 683 - 686.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
A. Buchman
Total Parenteral Nutrition-Associated Liver Disease
JPEN J Parenter Enteral Nutr, September 1, 2002; 26(5_suppl): S43 - S48.
[PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T Umapathi, V Chaudhry, D Cornblath, D Drachman, J Griffin, and R Kuncl
Head drop and camptocormia
J. Neurol. Neurosurg. Psychiatry, July 1, 2002; 73(1): 1 - 7.
[Full Text] [PDF]


Home page
PediatricsHome page
E. Helton, R. Darragh, P. Francis, F. J. Fricker, K. Jue, G. Koch, D. Mair, M. E. Pierpont, J. V. Prochazka, L. S. Linn, et al.
Metabolic Aspects of Myocardial Disease and a Role for L-Carnitine in the Treatment of Childhood Cardiomyopathy
Pediatrics, June 1, 2000; 105(6): 1260 - 1270.
[Abstract] [Full Text]


Home page
J Child NeurolHome page
R. Pons and D. C. De Vivo
Primary and Secondary Carnitine Deficiency Syndromes
J Child Neurol, November 1, 1995; 10(2_suppl): 2S8 - 2S24.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
G. Mingrone, R.M. Tacchino, M. Castagneto, E. Finotti, and A.V. Greco
Use of Even-Numbered Carbon Atom Dicarboxylic Salts in Parenteral Nutrition as Fuel Substrate
JPEN J Parenter Enteral Nutr, January 1, 1992; 16(1): 32 - 38.
[Abstract] [PDF]


Home page
J Child NeurolHome page
L. J. Willmore, W. J. Triggs, and J. M. Pellock
Valproate Toxicity: Risk-Screening Strategies
J Child Neurol, January 1, 1991; 6(1): 3 - 6.
[PDF]


Home page
Arch NeurolHome page
W. J. Triggs, T. P. Bohan, S.-N. Lin, and L. J. Willmore
Valproate-Induced Coma With Ketosis and Carnitine Insufficiency
Arch Neurol, October 1, 1990; 47(10): 1131 - 1133.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
M.E. Lambert, K. Shipley, I. Holbrook, E.B. Faragher, and M.H. Irving
Serum Carnitine Levels in Normal Individuals
JPEN J Parenter Enteral Nutr, March 1, 1988; 12(2): 143 - 146.
[Abstract] [PDF]


Home page
J Child NeurolHome page
C. K. Jablecki
Review Article: Electromyography in Infants and Children
J Child Neurol, October 1, 1986; 1(4): 297 - 318.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
G. Nanni, M. Pittiruti, I. Giovannini, G. Boldrini, P. Ronconi, and M. Castagneto
Plasma Carnitine Levels and Urinary Carnitine Excretion during Sepsis
JPEN J Parenter Enteral Nutr, July 1, 1985; 9(4): 483 - 490.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
L.I.G. Worthley, R.C. Fishlock, and A.M. Snoswell
Carnitine Balance and Effects of Intravenous L-Carnitine in Two Patients Receiving Long-Term Total Parenteral Nutrition
JPEN J Parenter Enteral Nutr, November 1, 1984; 8(6): 717 - 719.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. Kinoshita and N. Wakata
Lipid Storage Myopathy in Familial Hyperlipoproteinemia
Arch Neurol, May 1, 1984; 41(5): 551 - 554.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. P. Cruse, S. Di Mauro, J. Towfighi, and C. Trevisan
Familial Systemic Carnitine Deficiency
Arch Neurol, March 1, 1984; 41(3): 301 - 305.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
L.I.G. Worthley, R.C. Fishlock, and A.M. Snoswell
Carnitine Deficiency with Hyperbilirubinemia, Generalized Skeletal Muscle Weakness and Reactive Hypoglycemia in a Patient on Long-term Total Parenteral Nutrition: Treatment with Intravenous L-Carnitine
JPEN J Parenter Enteral Nutr, March 1, 1983; 7(2): 176 - 180.
[Abstract] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
D. Parker, A. W. Root, S. Schimmel, M. Andriola, and S. DiMauro
Encephalopathy and Fatal Myopathy in Two Siblings: Their Association With Partial Deficiency of Muscle Carnitine
Arch Pediatr Adolesc Med, July 1, 1982; 136(7): 598 - 601.
[Abstract] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
R. C. Tao and N. N. Yoshimura
Carnitine Metabolism and Its Application in Parenteral Nutrition
JPEN J Parenter Enteral Nutr, September 1, 1980; 4(5): 469 - 486.
[PDF]


Home page
Arch NeurolHome page
W. K. Engel
Dagen des Oordeels: Pathokinetic Mechanisms and Molecular Messengers (A Dramatic View)
Arch Neurol, June 1, 1979; 36(6): 329 - 339.
[Abstract] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
M. E. Pichichero and E. R. B. McCabe
Recurrent Reye's Syndrome
Arch Pediatr Adolesc Med, November 1, 1978; 132(11): 1097 - 1099.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by AAN Enterprises, Inc.